Solu Therapeutics

unlocking Impossible

Boston, United States · Founded 2023 · $72.0M raised

Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$72.0M
Last Round
$41.0M Series AApr 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Solu Therapeutics was established in May 2023 following the granting of an exclusive license to the CyTAC platform from GSK. The company is a clinical-stage biotech advancing its lead program through Phase 1 trials in chronic myelomonocytic leukemia, with additional CyTAC and TicTAC programs progressing toward development candidate status. By linking potent and selective small molecules to effector antibodies, Solu's platform targets cell surface proteins that are not addressable using other therapeutic modalities.

Summary

Solu Therapeutics is a Biotech company based in Boston, United States, founded in 2023. It has raised $72.0M in total across 2 rounds, most recently a $41.0M Series A round in Apr 2025. Investors include Hengdian Group Capital, Eli Lilly and DCVC (Data Collab).

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AApr 2025
$41.0M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Solu Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/solu-therapeutics"><img src="https://indexed.vc/api/badge/company/solu-therapeutics" alt="Solu Therapeutics on Indexed.vc" width="260" height="76" /></a>